A detailed history of Core Cap Advisors, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Core Cap Advisors, LLC holds 292 shares of BAX stock, worth $9,697. This represents 0.0% of its overall portfolio holdings.

Number of Shares
292
Holding current value
$9,697
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$32.85 - $40.26 $9,592 - $11,755
292 New
292 $11,000
Q1 2024

Aug 08, 2024

BUY
$37.88 - $43.77 $14,545 - $16,807
384 New
384 $16,000
Q4 2022

Feb 10, 2023

BUY
$49.7 - $57.71 $26,490 - $30,759
533 New
533 $27,000
Q2 2022

Aug 11, 2022

BUY
$63.83 - $80.0 $42,574 - $53,360
667 New
667 $43,000
Q1 2022

Apr 29, 2022

SELL
$76.85 - $89.45 $89,299 - $103,940
-1,162 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$74.57 - $87.19 $86,650 - $101,314
1,162 New
1,162 $100,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.